Pictet Group
Pictet Asset Management invests in MLase AG
Contact
Sarah Weigall
Media Relations
Group Communications
Pictet Group
+44 20 7847 5412
The funding will support the continuous growth of the business by expanding its innovative product portfolio in conjunction with its MedTech blue-chip OEM customer base, where MLase has built a strong reputation as a partner committed to high quality and service excellence.
Pictet Asset Management’s European Direct Lending strategy is pleased to announce its investment into MLase AG. The transaction represents its first investment in Germany through the newly launched lower mid-market-focussed direct lending strategy.
Sharing a long-term partnership approach, we are very pleased to support Maxburg and MLase in their next phase of growth in this quality-, excellence- and technology-driven segment of the MedTech market
Founded in 2007 and based in Germering, Germany, MLase is a leading developer and manufacturer of high-quality laser and light systems. MLase’s products are an integral component of a variety of OEM systems primarily used in medical applications such as refractive eye surgery, angiology and glaucoma treatment. The innovative solutions are the result of years of experience and in medical, physical, optical and electrotechnical advancements, making them ideal for demanding applications.
The buyout is backed by Maxburg Capital Management, a management- and partner-owned investment management company headquartered in Munich and focused on the German-speaking region, and which targets operationally stable and cash-flow producing SMEs. Since inception in 2014, Maxburg has completed 24 platform investments with a strong focus on succession solutions.